Planta Med 2023; 89(14): 1336
DOI: 10.1055/s-0043-1773991
Abstracts
Monday 3rd July 2023 | Poster Session I
Phytopharmacology I – General; respiratory; cardiac

Natural Acetylcholinesterase Inhibitors from Glycosmis parviflora stems

Thi Truc-Ly Duong
1   Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan
2   Can Tho University of Medicine and Pharmacy, Can Tho 90000, Vietnam
,
Tran Quoc-Dung Huynh
1   Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan
,
Ta-Wei Liu
3   School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan
,
Yun-Han Wang
1   Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan
,
Ching-Kuo Lee
1   Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan
3   School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan
› Author Affiliations
 
 

    Discovering natural medicines for Alzheimer's disease (AD) with minimal side effects is an ongoing challenge. In this study, we investigated the inhibitory effect of extracts and fractions from Glycosmis parviflora stems collected in Vietnam on acetylcholinesterase (AChE), an enzyme responsible for the hydrolysis of the cholinergic neurotransmitter acetylcholine. Our results revealed that the ethyl acetate extract exhibited the strongest AChE inhibitory activity. Through a bioassay-guided isolation approach, we identified eleven compounds, including a novel alkaloid, eight known alkaloids, one flavonoid and one saponin steroid. These compounds were assessed for their inhibitory activity against AChE, and among the tested compounds, O-methylglycosolone (6), 3-dimethoxy-10-methyl-9-acridone (1), skimmianine (4), and arborine (2) showed inhibitory effects. Notably, O-methylglycosolone was the most potent, with an IC50 value of 39.81±1.76 μM.

    Overall, our findings suggest that G. parviflora has the potential to protect neurotransmitters that have not been previously evaluated for AD. These results offer a promising direction for further investigation of G. parviflora and its compounds as potential natural medicines for AD.


    #

    Conflict of Interest

    The authors declare no conflict of interest.

    Publication History

    Article published online:
    16 November 2023

    © 2023. Thieme. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany